Lupin Pharmaceuticals Announces Tentative Approval Of Generic ZOLOFT(R)
Wed, 03 Jan 2007 08:00 AM EST
... Lupin Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sertraline Hydrochloride Tablets, 25mg, 50mg and 100mg. Final approval is expected upon the expiration of the first ANDA filer's 180-day marketing exclusivity in February 2007. [click link for full article] ...
Related Topics
- Sertraline
- Premenstrual Dysphoric Disorder
- Vaccine Testing & Approval
- Bupropion Extended-Release
- Tarceva
- Sertraline Oral Solution
- Drug Information
- Amphetamine and Dextroamphetamine
- Benazepril
- Triamterene and Hydrochlorothiazide
- Dutasteride
- Finasteride
- Lovastatin
- Rabeprazole
- Carisoprodol
- Zolpidem
- Tolterodine
- Fluoxetine
- Drug Side Effects
- Fentanyl Skin Patches

Not Signed In -

